EGFR and non-small cell lung carcinoma: Another potential target is epidermal growth factor receptor (EGFR), and a phase I clinical trial investigated EGFR-targeting CAR-T cells generated by the piggyBac transposon system in advanced pre-treated NSCLC [54].